Sirnaomics Ltd. Announces Board of Directors Composition

Story Highlights
Sirnaomics Ltd. Announces Board of Directors Composition

An update from Sirnaomics Ltd. ( (HK:2257) ) is now available.

Sirnaomics Ltd. has announced the composition of its Board of Directors, highlighting the roles and committee memberships of each member. This strategic structuring of the board aims to strengthen the company’s governance and leadership framework, potentially enhancing its operational efficiency and market positioning.

More about Sirnaomics Ltd.

Sirnaomics Ltd. is a biotechnology company specializing in the development of RNAi-based therapeutics for the treatment of diseases with unmet medical needs. The company operates within the pharmaceutical industry, focusing on innovative therapies targeting oncology and fibrosis indications.

YTD Price Performance: -9.54%

Average Trading Volume: 137,128

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$329.2M

For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App